in this issue
Chemical Week Magazine :: Top of the Week
House and Senate Approve FDA Reform Bill
11:39 AM MDT | June 1, 2012 | —DeeptiRamesh and Vincent Valk
The U.S. Senate and House of Representatives have approved separate bills that would revise FDA’s ability to oversee certain provisions related to pharmaceutical ingredients and includes a generic drug user fee program. The bills will now move to a House and Senate conference to reconcile differences in the two versions. The legislation, if finalized by Congress, would represent a significant victory for Socma, which for years has been urging lawmakers to take steps to make sure U.S. makers of active pharmaceutical ingredients (APIs) do not face unfair...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee